DEL RE, MARTA
DEL RE, MARTA
Altri
Clinical, Diagnostic and Therapeutic Framework of mHSPC and nmCRPC: A Multidisciplinary Consensus Project of the Italian Society for Uro-Oncology (SIUrO).
2024 D'Angelillo, Rm; Caffo, O; Borsellino, N; Cardone, G; Colloca, Gf; Conti, Gn; Del Re, M; Fanti, S; Jereczek-Fossa, Ba; Lapini, A; Pappagallo, Gl; Prayer Galetti, T; Bracarda, S.
Large−Scale Profiling of Extracellular Vesicles Identified miR−625−5p as a Novel Biomarker of Immunotherapy Response in Advanced Non−Small−Cell Lung Cancer Patients
2022 Pantano F.; Zalfa F.; Iuliani M.; Simonetti S.; Manca P.; Napolitano A.; Tiberi S.; Russano M.; Citarella F.; Foderaro S.; Vulpis E.; Zingoni A.; Masuelli L.; Bei R.; Ribelli G.; Del Re M.; Danesi R.; Vincenzi B.; Perrone G.; Tonini G.; Santini D.
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
2022 Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.; Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R.
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
2021 Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.; Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Clinical, Diagnostic and Therapeutic Framework of mHSPC and nmCRPC: A Multidisciplinary Consensus Project of the Italian Society for Uro-Oncology (SIUrO). | D'Angelillo, Rm; Caffo, O; Borsellino, N; Cardone, G; Colloca, Gf; Conti, Gn; Del Re, M; Fanti, S...; Jereczek-Fossa, Ba; Lapini, A; Pappagallo, Gl; Prayer Galetti, T; Bracarda, S. | 2024-01-01 | CLINICAL GENITOURINARY CANCER | - | 1.01 Articolo in rivista | D_Angelillo_2025.pdf |
| Large−Scale Profiling of Extracellular Vesicles Identified miR−625−5p as a Novel Biomarker of Immunotherapy Response in Advanced Non−Small−Cell Lung Cancer Patients | Pantano F.; Zalfa F.; Iuliani M.; Simonetti S.; Manca P.; Napolitano A.; Tiberi S.; Russano M.; C...itarella F.; Foderaro S.; Vulpis E.; Zingoni A.; Masuelli L.; Bei R.; Ribelli G.; Del Re M.; Danesi R.; Vincenzi B.; Perrone G.; Tonini G.; Santini D. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-02435-v3.pdf |
| Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients | Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.;... Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R. | 2022-01-01 | ESMO OPEN | - | 1.04 Replica / breve intervento (e simili) | - |
| Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients | Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.;... Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R. | 2021-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | - |